BioAge Labs, Inc. (BIOA)
8.06
-0.03
(-0.37%)
USD |
NASDAQ |
Sep 18, 16:00
8.06
0.00 (0.00%)
Pre-Market: 20:00
BioAge Labs Free Cash Flow : -88.09M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -88.09M |
| March 31, 2026 | -88.63M |
| December 31, 2025 | -82.35M |
| September 30, 2025 | -59.15M |
| June 30, 2025 | -58.32M |
| March 31, 2025 | -54.00M |
| Date | Value |
|---|---|
| December 31, 2024 | -51.89M |
| September 30, 2024 | -55.23M |
| June 30, 2024 | -47.85M |
| March 31, 2024 | -43.18M |
| December 31, 2023 | -37.53M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 13.56B |
| Pfizer Inc. | 10.99B |
| Oramed Pharmaceuticals, Inc. | -5.820M |
| Liquidia Corp. | 150.69M |
| Neumora Therapeutics, Inc. | -180.96M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.26M |
| Cash from Investing (Quarterly) | -164.51M |
| Cash from Financing (Quarterly) | 15.97M |
| Free Cash Flow Per Share (Quarterly) | -0.4369 |
| Free Cash Flow to Equity (Quarterly) | -18.39M |
| Free Cash Flow to Firm (Quarterly) | -19.59M |
| Free Cash Flow Yield | -27.45% |